News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

John Dent, MD

Articles by John Dent, MD

Use of an Intravenous Contrast Agent (Optison) to Enhance Echocardiography: Efficacy and Cost Implications

ByLeslee J. Shaw, PhD,Linda Gillam, MD,Steven Feinstein, MD,John Dent, MD,Gary Plotnick, MD,for the Optison Multicenter Study Group

September 25th 1998

Latest Updated Articles

Use of an Intravenous Contrast Agent (Optison) to Enhance Echocardiography: Efficacy and Cost Implications
Published: September 25th 1998 | Updated:

Trending on AJMC

TrumpRx Launch Brings Savings—and Uncertainty

5 Things to Know About the Oral GLP-1 Era

Exploring Identity, Appearance Experiences Among Patients With Alopecia

Stroke Subtype Does Not Affect Efficacy of Asundexian for Second Stroke Prevention

Real-World Evidence Backs Acalabrutinib in CLL Care

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

© 2025 MJH Life Sciences^®

All rights reserved.

Alt Text

Alt Text